Friday, April 12, 2013

Report: Major League Baseball paid for documents related to doping case


Major League Baseball is adamant about identifying players who are linked to receiving performance-enhancing drugs from the now-closed Biogenesis of America.

In fact, MLB is so desperate that the commissioner's office reportedly paid off a former employee of the defunct Florida anti-aging clinic in order to obtain documents relevant to the case. Additionally, the report also stated that at least one player linked to the clinic purchased documents from a former employee with the intent to destroy the incriminating evidence against them. Two unidentified sources also claim that other players tried to buy documents from the clinic, as well.

According to the New York Times, the payments made by MLB did not exceed more than several thousand dollars for the documents. However, the fact that they shelled out any money at all for the pieces of potential evidence is unusual. League officials opted to take the unprecedented move of buying the documents because, with no subpoena power, they feared they might not have access to the material if it somehow wound up in the possession of players.

The Miami New Times was the first to uncover the Biogenesis scandal when it obtained documents which implicated Yankees slugger Alex Rodriguez among the clinic's clients. Other big league players who have since been identified as clients include Melky Cabrera, Gio Gonzalez, Bartolo Colon, Nelson Cruz, Yasmani Grandal, and perhaps the biggest name, Ryan Braun.

Each player has strongly denied obtaining any banned drugs from the clinic, which operated out of Coral Gables, Fla.

MLB filed a lawsuit against Bigenesis last month accusing them of damaging the sport by providing players with banned substances. Among the banned drugs the suit alleges the clinic supplied are testosterone, human growth hormone, and human chorionic gonadotropin.

MLB Commissioner Bud Selig says the league continues to undergo a "very thorough investigation" into the matter.

Via New York Times

No comments:

Post a Comment